Last week Despoina attended the Beilstein Nanotechnology Symposium, focused on the topic of “The Next Generation of Nanomedicines”, organized by the Beilstein Institute. In the Symposium, the latest advances of nanomedicine for precise targeting therapies to unlock their potential for drug and gene delivery applications were addressed. Despoina presented in a flash talk of her poster titled: “The combination of 2D Immunomodulators and Fibrin Hydrogels as a Neoadjuvant for post-resection Glioblastoma”.